NCT06387810 2024-07-10
undetermined
Peking Union Medical College Hospital
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06345300 2024-04-03
NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT02717091 2020-09-10
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer
Nagoya University
Phase 2 Unknown
NCT03850769 2020-03-10
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Unknown